← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2008Last known activity
Nov 1, 2010
Timeline
2000s
- Jan 1, 2005
The Wayne D. Kuni and Joan E. Kuni Foundation— Founded
Drugs by trial phase (10 distinct, 4 trials)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Carcinoma, Non-Small-Cell Lung
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lung Neoplasms
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Waldenstrom Macroglobulinemia
Recent trials (4)
- NCT01228084CollaboratorPhase 2Nov 1, 2010
- NCT01253642CollaboratorPhase 2Jul 12, 2010
- NCT00850785CollaboratorPhase 1Jan 1, 2009
- NCT00789776CollaboratorPhase 1/Phase 2Oct 1, 2008
Details
- Founded
- Vancouver, WA, US Jan 1, 2005
- Last known activity
- Nov 1, 2010